May 29th 2025, 9:00pm
Dr. Jared Weiss sat down for an interview to discuss a trial evaluating JNJ-1900, an immune-stimulating radiation sensitizer, in those with lung cancer.
May 28th 2025, 8:00pm
Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer.
May 27th 2025, 8:00pm
A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.
May 27th 2025, 1:00pm
Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used.
May 25th 2025, 6:00pm
IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell.
May 23rd 2025, 8:00pm
Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives.
May 22nd 2025, 7:00pm
Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.
May 21st 2025, 7:00pm
Dr. Shirley D’Sa discusses how treatment strategies for WM have evolved over the course of her career.
May 20th 2025, 8:00pm
Arterial thrombosis may occur years before cancer diagnosis, suggesting it could be a risk factor, according to Dr. Tiziano Barbui.
May 20th 2025, 7:00pm
Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to healthy tissue, per Dr. Curtiland Deville Jr.
Delving into the Evaluation of JNJ-1900 Trial for Lung Cancer Treatment
Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis
Guiding Light: A Journey of Support and Hope
Tracing a Five-Generation Cancer Legacy Through Genetic Discovery